Coretag Therapeutics Company

Coretag develops both diagnostic and therapeutic radioligands. Based on NC-Tracer, different radioligands can be developed. The company pipeline currently consists of Actinocore and Thermcore. Actinocore is a targeted brachytherapy directly from the necrotic core inside solid tumors and metastases. Thermcore is a targeted treatment directly from inside the necrotic core of solid tumors and metastases.